Anika Therapeutics PE ratio ANIK

Share price divided by earnings per share over the last twelve months, since 2012.

Today, Oct 23, 2026: n/m; losses over the last year
Last meaningful: 74.2×; Apr 2022
10-year median: 24.6×
10-year range: 13.5× to 97.4×
Peer median: 22.3×

Anika Therapeutics has no meaningful PE ratio today: it lost $0.27 a share over the last twelve months, and a PE needs earnings.

It was last meaningful in Apr 2022, at 74.2×.

On the days it had one over the last ten years, its median was 24.6×, from 13.5× in Mar 2020 to 97.4× in Mar 2022.

PE ratio over time

median 24.6×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2022	74.2×	74.2×	97.4×
2021	n/m a value too high to mean anything
2020	41.8×	13.5×	49.4×
2019	24.5×	17.9×	35.8×
2018	25.0×	17.9×	35.3×
2017	25.3×	19.7×	26.5×
2016	21.0×	17.9×	25.8×
2015	21.2×	14.0×	24.1×
2014	16.2×	15.2×	33.7×
2013	29.4×	14.3×	30.7×
2012	13.3×	13.1×	20.4×

Against its peers

Companies in Medical - Instruments & Supplies nearest Anika Therapeutics' size, closest first, today.

Company	PE ratio
ANIKAnika Therapeutics	n/m
INFUInfuSystem	34.0×
UTMDUtah Medical Products	22.6×
EMBCEmbecta	4.6×
PDEXPro DEX	15.1×
TCMDTactile Systems Technology	21.9×
MDXGMimedx	97.8×
MOVMovado	17.5×
KEQUKewaunee Scientific	11.9×
IRMDIradimed	47.9×
STAAStaar Surgical	323×
Peer median	22.3×

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Anika Therapeutics

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.